NOVARTIS CAP P Performance

66989HAH1   90.85  3.29  3.76%   
The bond secures a Beta (Market Risk) of 0.0276, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NOVARTIS's returns are expected to increase less than the market. However, during the bear market, the loss of holding NOVARTIS is expected to be smaller as well.

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NOVARTIS CAP P are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, NOVARTIS is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Yield To Maturity4.891
  

NOVARTIS Relative Risk vs. Return Landscape

If you would invest  9,122  in NOVARTIS CAP P on October 21, 2024 and sell it today you would earn a total of  122.00  from holding NOVARTIS CAP P or generate 1.34% return on investment over 90 days. NOVARTIS CAP P is generating 0.0272% of daily returns and assumes 0.9395% volatility on return distribution over the 90 days horizon. Simply put, 8% of bonds are less volatile than NOVARTIS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon NOVARTIS is expected to generate 1.11 times more return on investment than the market. However, the company is 1.11 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.03 per unit of risk.

NOVARTIS Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for NOVARTIS's investment risk. Standard deviation is the most common way to measure market volatility of bonds, such as NOVARTIS CAP P, and traders can use it to determine the average amount a NOVARTIS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.029

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns66989HAH1

Estimated Market Risk

 0.94
  actual daily
8
92% of assets are more volatile

Expected Return

 0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average NOVARTIS is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NOVARTIS by adding it to a well-diversified portfolio.

About NOVARTIS Performance

By analyzing NOVARTIS's fundamental ratios, stakeholders can gain valuable insights into NOVARTIS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NOVARTIS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NOVARTIS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.